N2AR34 Stock Overview
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Inari Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$50.94 |
| 52 Week High | US$52.15 |
| 52 Week Low | US$47.82 |
| Beta | 1.26 |
| 1 Month Change | 0% |
| 3 Month Change | -1.47% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 43.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| N2AR34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | -4.1% |
| 1Y | n/a | 6.6% | -11.4% |
Return vs Industry: Insufficient data to determine how N2AR34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how N2AR34 performed against the BR Market.
Price Volatility
| N2AR34 volatility | |
|---|---|
| N2AR34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.4% |
| 10% least volatile stocks in BR Market | 2.7% |
Stable Share Price: N2AR34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine N2AR34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 800 | Bill Hoffman | www.inarimedical.com |
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment.
Inari Medical, Inc. Fundamentals Summary
| N2AR34 fundamental statistics | |
|---|---|
| Market cap | R$21.84b |
| Earnings (TTM) | -R$80.10m |
| Revenue (TTM) | R$1.79b |
12.2x
P/S Ratio-272.6x
P/E RatioIs N2AR34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| N2AR34 income statement (TTM) | |
|---|---|
| Revenue | US$335.63m |
| Cost of Revenue | US$35.63m |
| Gross Profit | US$300.00m |
| Other Expenses | US$315.01m |
| Earnings | -US$15.01m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Nov 02, 2022
| Earnings per share (EPS) | -0.28 |
| Gross Margin | 89.38% |
| Net Profit Margin | -4.47% |
| Debt/Equity Ratio | 0% |
How did N2AR34 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/10/29 21:04 |
| End of Day Share Price | 2022/08/01 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Inari Medical, Inc. is covered by 19 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Rescott | Baird |
| Nisala Weerasuriya | Berenberg |
| Travis Steed | BofA Global Research |